ISOPROTERENOL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for isoproterenol hydrochloride and what is the scope of patent protection?
Isoproterenol hydrochloride
is the generic ingredient in six branded drugs marketed by 3M, Alpharma Us Pharms, Sanofi Aventis Us, Abbott, Abraxis Pharm, Am Regent, Amneal, Amphastar Pharms Inc, Amring Pharms, Avet Lifesciences, Baxter Hlthcare, Cipla, Eugia Pharma, Hikma, Hospira, Intl Medication, Micro Labs, Nexus, Norvium Bioscience, Penn Life, Somerset Theraps Llc, Zydus Pharms, Bausch, Lilly, Armour Pharm, DEY, Parke Davis, and Fisons, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for isoproterenol hydrochloride. Eleven suppliers are listed for this compound.
Summary for ISOPROTERENOL HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 28 |
NDAs: | 35 |
Drug Master File Entries: | 14 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Clinical Trials: | 25 |
Patent Applications: | 1,374 |
What excipients (inactive ingredients) are in ISOPROTERENOL HYDROCHLORIDE? | ISOPROTERENOL HYDROCHLORIDE excipients list |
DailyMed Link: | ISOPROTERENOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ISOPROTERENOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alberta | Phase 1 |
Ningbo No. 1 Hospital | Phase 4 |
Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
Pharmacology for ISOPROTERENOL HYDROCHLORIDE
Drug Class | beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic beta-Agonists |
US Patents and Regulatory Information for ISOPROTERENOL HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eugia Pharma | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 211864-001 | Feb 9, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 083283-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | SOLUTION;INHALATION | 006327-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
3m | DUO-MEDIHALER | isoproterenol hydrochloride; phenylephrine bitartrate | AEROSOL, METERED;INHALATION | 013296-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.